T1	Participants 620 625	women
T2	Participants 532 570	Premenopausal and postmenopausal women
T3	Participants 962 982	two treatment groups
T4	Participants 1054 1074	two treatment groups
T5	Participants 1231 1252	two treatment groups.
T6	Participants 1439 1458	two treatment group
